Please login to the form below

Not currently logged in
Email:
Password:

Roche files patent lawsuit against Teva for osteoporosis drug

Roche files a lawsuit against generic manufacturer Teva over an alleged patent violation on its osteoporosis treatment, Boniva

Swiss pharmaceutical company Roche has filed a lawsuit against Israel-headquartered generic manufacturer Teva over an alleged patent violation on its osteoporosis treatment Boniva (ibandronate).

A Roche spokesperson said the lawsuit was instituted to prevent Teva from marketing a generic version of Boniva 150 mg tablets. The basic patent runs until 2012, with further patents protecting the drug until 2023.

Boniva recorded sales of CHF 374m (USD 315.7m) in H1 FY07, according to Roche.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics